Cargando…
Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics
Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disease driven by immune dysregulation and skin barrier dysfunction. We are currently experiencing a new era of understanding of the pathogenesis of AD and, as a consequence, a new era of innovation in therapeutics, including small molecule...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875213/ https://www.ncbi.nlm.nih.gov/pubmed/33911806 http://dx.doi.org/10.5021/ad.2021.33.1.1 |